SARS
In April 2020, the distributed computing platform was restarted by the Ibercivis Foundation and the Spanish National Research Council in order to screen existing drugs for antiviral activity against Severe acute respiratory syndrome coronavirus 2, the causative agent of the COVID-19 pandemic.